Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 42Precursor Cell Lymphoblastic Leukemia-Lymphoma 36Leukemia, Lymphocytic, Chronic, B-Cell 36Myelodysplastic Syndromes 33Multiple Myeloma 32Leukemia 32Hodgkin Disease 32Lymphoma, Non-Hodgkin 31Lymphoma, Mantle-Cell 28Lymphoma, Large B-Cell, Diffuse 26Lymphoma, Follicular 22Lymphoma 22Lymphoma, B-Cell, Marginal Zone 21Myeloproliferative Disorders 19Lymphoma, Large-Cell, Immunoblastic 19Leukemia, Myeloid, Chronic-Phase 19Burkitt Lymphoma 19Leukemia, Myelogenous, Chronic, BCR-ABL Positive 18Congenital Abnormalities 18Waldenstrom Macroglobulinemia 16Anemia, Refractory, with Excess of Blasts 16Leukemia, Myelomonocytic, Chronic 15Recurrence 12Myelodysplastic-Myeloproliferative Diseases 12Dendritic Cell Sarcoma, Interdigitating 12Blast Crisis 12Sezary Syndrome 11Lymphoma, T-Cell, Cutaneous 11Leukemia, Prolymphocytic 11Hematologic Neoplasms 11

Interventions

Voriconazole 3posaconazole 2Fluconazole 2Caspofungin 2liposomal amphotericin B 1Standard of Care 1ProMune 1Lymphatic Irradiation 1Levofloxacin 1Cyclosporine 1Antilymphocyte Serum 1Amphotericin B 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Mycoses × Cyclosporine × Clear all
NCT00896493 2023-05-11

Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma

Stanford University

Phase 2 Completed
38 enrolled 21 charts
DermatologicLymphoid

Lymphoma, Non-Hodgkin, Mycoses, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡